Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-16 | Amended | $66,695,817 | $7,499,999 | Equity Only | 06b | SEC link |
| 2025-04-01 | New | $59,195,818 | $59,195,818 | Equity Only | 06b | SEC link |
| 2020-07-02 | New | $40,734,932 | $40,734,932 | Equity Only | 06b | SEC link |
| 2018-07-09 | New | $40,249,995 | $40,249,995 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Zina Affas Besse | Director |
| Pieter Boelhouwer | Director |
| Pavan Cheruvu | Director |
| Charles Dunn | Director |
| David Alexandre C. Gros | Executive |
| Ken Horne | Director |
| James Januzzi | Director |
| Komal Joshi | Executive |
| Andrew Levin | Director |
| Rebecca Luse | Director |
| Luse Rebecca | Director |
| Alvin Shih | Director, Executive |